Mitesh

The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...]

The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.

The following price concessions granted in April 2026 have rolled over to May 2026: Drug  Pack size Price concession Candesartan 4mg tablets 7 £0.75 Labetalol 200mg tablets 56 £17.87 Lacidipine 4mg tablets 28 £1.95 Ramipril 2.5mg capsules 28 £0.94 Sumatriptan 100mg tablets 6 £1.10 Please note any rolled over prices can be adjusted upwards if [...]

The post Rolled Over Price Concessions For May 2026 appeared first on Community Pharmacy England.

24 new products (including those with multiple flavours) have been added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 May 2026. Community Pharmacy England, on behalf of pharmacy owners, applied to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) for these products to [...]

The post 24 products added to the Discount Not Deducted (DND) list from May 2026 appeared first on Community Pharmacy England.

Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse. There have been reports of worsening nasal congestion (rebound congestion) when the effects of nasal decongestant sprays or drops containing xylometazoline hydrochloride and oxymetazoline hydrochloride, referred to hereafter as ‘xylometazoline’ and ‘oxymetazoline’, wear [...]

The post MHRA Drug Safety Update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/22 Date issued: 28 April 2026 Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site. DMRC reference number: DMRC-39135670 Company name: Amarox Limited Medicine Details Sertraline 100mg [...]

The post MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) appeared first on Community Pharmacy England.